Airbus SeEURONEXT: AIR

Q1 2026 Financial Statements

· MarketScreener

‌Contents

Airbus SE Unaudited Condensed Interim IFRS Consolidated Financial Information for the three-month period ended 31 March 2026
  1. Airbus SE Unaudited Condensed Interim IFRS Consolidated Financial Statements 2

    Unaudited Condensed Interim IFRS Consolidated Income Statement 2

    Unaudited Condensed Interim IFRS Consolidated Statement of Comprehensive Income 3

    Unaudited Condensed Interim IFRS Consolidated Statement of Financial Position 4

    Unaudited Condensed Interim IFRS Consolidated Statement of Cash Flows 6

    Unaudited Condensed Interim IFRS Consolidated Statement of Changes in Equity 7

  2. Notes to the Airbus SE Unaudited Condensed Interim IFRS Consolidated Financial Statements 8

    1. The Company 8

    2. Accounting Policies 8

    3. Geopolitical and Macroeconomic Environment 8

    4. Acquisitions and Disposals 8

    5. Related Party Transactions 9

    6. Segment Information 9

    7. Revenues and Gross Margin 10

    8. Research and Development Expenses 10

    9. Other Income and Other Expenses 11

    10. Share of Profit from Investments Accounted for under the Equity Method and Other Income from Investments 11

    11. Total Financial Result 11

    12. Income Taxes 11

    13. Earnings per share 11

    14. Investments Accounted for under the Equity Method 11

    15. Other Investments and Other Long-Term Financial Assets 12

    16. Inventories 12

    17. Provisions 12

    18. Other Financial Assets and Other Financial Liabilities 12

    19. Other Assets and Other Liabilities 13

    20. Total Equity 14

    21. Net Cash 14

    22. Financial Instruments 16

    23. Litigation and Claims 17

    24. Number of Employees 18

    25. Events after the Reporting Date 18

‌1‌ Airbus SE Unaudited Condensed Interim IFRS Consolidated Financial Statements

‌Unaudited Condensed Interim‌

IFRS Consolidated Income Statement

(in € million)

Note

1 January -

31 March 2026

1 January -

31 March 2025

Revenues

7

12,651

13,542

Cost of sales

(11,095)

(11,664)

Gross margin

7

1,556

1,878

Selling expenses

(218)

(219)

Administrative expenses

(421)

(446)

Research and development expenses

8

(730)

(673)

Other income

9

55

33

Other expenses

9

(38)

(121)

Share of profit from investments accounted for under the equity method

10

17

29

Other income from investments

10

3

(8)

Profit before financial result and income taxes (EBIT)

224

473

Interest income

11

176

209

Interest expenses

11

(175)

(189)

Other financial result

11

465

601

Total financial result

11

466

621

Income taxes

12

(139)

(349)

Profit for the period

551

745

Attributable to:

Equity owners of the parent (Net income)

586

793

Non-controlling interests

(35)

(48)

Earnings per share

€

€

Basic

13

0.74

1.01

Diluted

13

0.74

1.01

The accompanying notes are an integral part of these Unaudited Condensed Interim IFRS Consolidated Financial Statements.

‌Unaudited Condensed Interim‌

IFRS Consolidated Statement of Comprehensive Income

(in € million)

1 January -

31 March 2026

1 January -

31 March 2025

Profit for the period

551

745

Other comprehensive income:

Items that will not be reclassified to profit or loss:

Remeasurement of the defined benefit pension plans

244

171

Income tax relating to re-measurement of the defined benefit pension plans

(108)

(23)

Change in fair value of financial assets

(98)

(1)

Income tax relating to change in fair value of financial assets

0

0

Transfer on disposal of fair value through OCI equity instruments

34

0

Share of change from investments accounted for under the equity method

(1)

(5)

Items that may be reclassified to profit or loss:

Foreign currency translation differences for foreign operations

74

(143)

Change in fair value of cash flow hedges

(1,076)

2,002

Income tax relating to change in fair value of cash flow hedges

257

(548)

Change in fair value of financial assets

(110)

30

Income tax relating to change in fair value of financial assets

1

0

Share of change from investments accounted for under the equity method

(11)

(15)

Other comprehensive income, net of tax

(794)

1,469

Total comprehensive income for the period

(243)

2,214

Attributable to:

Equity holders of the parent

(202)

2,226

Non-controlling interests

(41)

(12)

The accompanying notes are an integral part of these Unaudited Condensed Interim IFRS Consolidated Financial Statements.

‌Unaudited Condensed Interim‌

IFRS Consolidated Statement of Financial Position

(in € million)

Note

31 March 2026

31 December 2025

Assets

Non-current assets

Intangible assets

16,837

16,847

Property, plant & equipment

20,941

20,893

Investment property

68

68

Investments accounted for under the equity method

14

2,375

2,360

Other investments & other long-term financial assets

15

5,613

5,470

Non-current contract assets

31

17

Non-current other financial assets

18

654

1,070

Non-current other assets

19

3,073

2,762

Deferred tax assets

2,000

1,808

Non-current securities

21

10,366

9,997

Non-current assets

61,958

61,292

Current assets

Inventories

16

46,922

41,676

Trade receivables

5,243

5,454

Current portion of other long-term financial assets

15

905

734

Current contract assets

1,837

1,639

Current other financial assets

18

2,349

2,557

Current other assets

19

3,950

3,760

Current tax assets

601

543

Current securities

21

2,999

3,093

Cash and cash equivalents

21

11,872

14,128

Current assets

76,678

73,584

Assets and disposal group of assets classified as held for sale

4

64

63

Total assets

138,700

134,939

(in € million)

Note

31 March 2026

31 December 2025

Equity and liabilities

Equity attributable to owners of the parent

Capital stock

793

793

Share premium

4,002

4,002

Retained earnings

23,277

22,334

Other components of equity

(1,026)

(70)

Treasury shares

(955)

(955)

Equity attributable to owners of the parent

26,091

26,104

Non-controlling interests

88

80

Total equity

20

26,179

26,184

Liabilities

Non-current liabilities

Non-current provisions

17

3,759

3,976

Long-term financing liabilities

21

9,055

9,063

Non-current contract liabilities

26,468

26,484

Non-current other financial liabilities

18

5,097

4,809

Non-current other liabilities

19

450

477

Deferred tax liabilities

387

428

Non-current deferred income

7

7

Non-current liabilities

45,223

45,244

Current liabilities

Current provisions

17

4,163

4,369

Short-term financing liabilities

21

5,515

5,186

Trade liabilities

16,337

15,878

Current contract liabilities

33,859

32,112

Current other financial liabilities

18

1,264

1,000

Current other liabilities

19

5,291

4,223

Current tax liabilities

224

133

Current deferred income

560

528

Current liabilities

67,213

63,429

Disposal group of liabilities classified as held for sale

4

85

82

Total liabilities

112,521

108,755

Total equity and liabilities

138,700

134,939

The accompanying notes are an integral part of these Unaudited Condensed Interim IFRS Consolidated Financial Statements.

‌Unaudited Condensed Interim‌

IFRS Consolidated Statement of Cash Flows

(in € million)

Note

1 January -

31 March 2026

1 January -

31 March 2025

Operating activities

Profit for the period attributable to equity owners of the parent (Net income)

586

793

Loss for the period attributable to non-controlling interests

(35)

(48)

Adjustments to reconcile profit for the period to cash provided by (used for) operating activities:

Depreciation and amortisation

686

626

Deferred tax expense (income)

(76)

(30)

Change in income tax assets, income tax liabilities and provisions for income tax

31

190

Results on disposals of non-current assets

8

17

Results of investments accounted for under the equity method

(17)

(29)

Change in current and non-current provisions

(69)

136

Contribution to plan assets

(77)

(75)

Others elements

(34)

(456)

Change in other operating assets and liabilities

(2,886)

(900)

Cash provided by (used for) operating activities

21

(1,883)

224

Investing activities

Purchases of intangible assets, property plant and equipment, investment property

(615)

(597)

Proceeds from disposals of intangible assets, property plant and equipment and investment property

5

8

Acquisitions of subsidiaries and businesses (net of cash acquired) and joint ventures

4

(1)

0

Payments for investments accounted for under the equity method, other investments and other long-term financial assets

(274)

(228)

Proceeds from disposals of investments accounted for under the equity method, other investments and other long-term financial assets

422

276

Dividends paid by companies accounted for under the equity method

4

0

Change in securities

21

(319)

(657)

Cash (used for) investing activities

21

(778)

(1,198)

Financing activities

Change in financing liabilities

21

227

(41)

Change in capital and non-controlling interests

20

1

67

Change in treasury shares

20

0

(102)

Cash provided by (used for) financing activities

21

228

(76)

Effect of foreign exchange rate changes on cash and cash equivalents

179

(278)

Net (decrease) in cash and cash equivalents

21

(2,254)

(1,328)

Cash and cash equivalents at beginning of period

21

14,140

15,010

Cash and cash equivalents at end of period

21

11,886

13,682

thereof presented as cash and cash equivalents

21

11,872

13,676

thereof presented as part of disposal groups classified as held for sale

4

14

6

The accompanying notes are an integral part of these Unaudited Condensed Interim IFRS Consolidated Financial Statements.

‌Unaudited Condensed Interim‌

IFRS Consolidated Statement of Changes in Equity

(In € million)

Equity attributable to

owners of the

parent

Non-controlling

interests

Total Equity

Balance at 1 January 2025

19,606

90

19,696

Profit for the period

793

(48)

745

Other comprehensive income

1,433

36

1,469

Total comprehensive income of the period

2,226

(12)

2,214

Capital increase

0

0

0

Share-based payment

263

0

263

Equity transaction

6

13

19

Change in treasury shares

(102)

0

(102)

Balance at 31 March 2025

21,999

91

22,090

Balance at 1 January 2026

26,104

80

26,184

Profit for the period

586

(35)

551

Other comprehensive income

(788)

(6)

(794)

Total comprehensive income of the period

(202)

(41)

(243)

Capital increase

0

0

0

Share-based payment

234

0

234

Equity transaction

(45)

49

4

Change in treasury shares

0

0

0

Balance at 31 March 2026

26,091

88

26,179

‌2‌ Notes to the Airbus SE Unaudited Condensed Interim IFRS Consolidated Financial Statements
  1. ‌The Company‌

    The accompanying Unaudited Condensed Interim IFRS Consolidated Financial Statements present the financial position and the results of operations of Airbus SE (together with its subsidiaries referred to as "the Company"), a European public limited-liability company (Societas Europaea) with its seat (statutaire zetel) in Amsterdam, The Netherlands, its registered address at Mendelweg 30, 2333 CS Leiden, The Netherlands, and registered with the Dutch Commercial Register (Handelsregister) under number 24288945. The Company's reportable segments are Airbus, Airbus Helicopters and Airbus Defence and Space (see "- Note 6: Segment Information"). The Company is listed on the European stock exchanges in Paris, Frankfurt am Main, Madrid, Barcelona, Valencia and Bilbao. The Unaudited Condensed Interim IFRS Consolidated Financial Statements were authorised for issue by the Company's Board of Directors on 28 April 2026.

  2. ‌Accounting Policies‌

    The Unaudited Condensed Interim IFRS Consolidated Financial Statements (including the financial position and the results of operations of the Company as at and for the three months ended 31 March 2026) are prepared in accordance with International Financial Reporting Standards ("IFRS"), issued by the International Accounting Standards Board ("IASB") as endorsed by the European Union ("EU"). They are prepared and reported in euro ("€") and all values are rounded to the nearest million appropriately. Due to rounding, numbers presented may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures.

    These Unaudited Condensed Interim IFRS Consolidated Financial Statements are prepared in compliance with IAS 34 and should be read in conjunction with the IFRS Consolidated Financial Statements as of 31 December 2025. The Company's accounting policies and methods are unchanged compared to 31 December 2025. The implementation of new or amended standards has no material impact on the Unaudited Condensed Interim IFRS Consolidated Financial Statements as of 31 March 2026.

    Use of Estimates and Judgements

    In preparing the Unaudited Condensed Interim IFRS Consolidated Financial Statements, management makes assumptions and estimates. These estimates are revised if the underlying circumstances have evolved or in light of new information. The key estimates and judgements of the Company that have a significant influence on the amounts recognised in the Unaudited Condensed Interim IFRS Consolidated Financial Statements are the same as those described in the Company's IFRS Consolidated Financial Statements as of 31 December 2025.

  3. ‌Geopolitical and Macroeconomic Environment‌

    The Company continues to operate in a complex and dynamic environment, in particular with geopolitical uncertainties and specific supply chain challenges, notably engine shortages from one supplier.

    Continued instability in the geopolitical environment persists in creating points of vigilance for the Company. While the current conflict in the Middle East is impacting trade routes (and in particular the supply of oil and other related products) and has led to disruptions of air traffic, as of 31 March 2026, no material impact has been recognised in the Company's Unaudited Condensed Interim IFRS Consolidated Financial Statements. The Company continues to assess this situation as it evolves.

  4. ‌Acquisitions and Disposals‌

    Spirit Acquisition

    On 8 December 2025, after having received all required regulatory approvals, the Company completed the acquisition of certain Spirit AeroSystems, Inc. businesses related mainly to the execution by Spirit of certain supply contracts with Airbus (collectively, the "Spirit Acquired Businesses"). A preliminary goodwill of US$ 236 million (€ 203 million) was recognised as of 31 December 2025. The

    Company continues to review information relating to events or circumstances existing at the acquisition date that could impact the fair value estimates. The one-year window for the completion of the purchase price allocation ("PPA") will end at the latest in December 2026.

    Other acquisitions and disposals

    On 23 October 2025, the Company, Leonardo and Thales announced the signature of a memorandum of understanding to create a leading European player in space. The Company will contribute with its Space Systems and Space Digital businesses, coming from Airbus Defence and Space. The new company could be operational in 2027, subject to regulatory approvals and satisfaction of other closing conditions. Ownership of the new company will be shared among the parent companies, with Airbus, Leonardo and Thales owning respectively 35%, 32.5% and 32.5% stakes. It will operate under joint control, with a balanced governance structure among shareholders. As of 31 March 2026, this transaction did not meet the criteria to be classified as held for sale.

    On 7 November 2025, Satair, an Airbus company, entered into an agreement to acquire Unical Aviation Inc. ("Unical"), a global aircraft parts and components supplier of Used Serviceable Material ("USM") and its subsidiary ecube, a global expert in aircraft storage, disassembly, and transition services. The acquisition includes Unical's and ecube's six operational sites and offices across North America, Spain, and the United Kingdom, adding a strategic expansion to Satair Int's global footprint. The transaction is subject to the customary regulatory approvals and is still expected to be finalised in the first half-year 2026.

    On 23 March 2026, Airbus entered into a definitive agreement with the Cobham Ultra group, a portfolio company of Advent, for the acquisition of Ultra Cyber Ltd, based in Maidenhead, United Kingdom. This strategic move reinforces Airbus' position as a trusted, sovereign partner for the UK and a key supplier to its allies, while strengthening its presence in the European cybersecurity landscape. Closing of the transaction is subject to customary regulatory approvals and is expected in the second half-year 2026.

    Assets and Disposal Groups Classified as Held for Sale

    As of 31 March 2026, the Company continues intending to divest one of its subsidiaries. The assets and liabilities relating to this disposal are classified as held for sale for a net amount of € -21 million as of 31 March 2026. The transaction is expected to be closed in 2026.

  5. ‌Related Party Transactions‌

    The Company has entered into various transactions with related entities; carried out in the normal course of business.

  6. ‌Segment Information‌

    The following tables present information with respect to the Company's business segments. As a rule, inter-segment transfers are carried out on an arm's length basis. Inter-segment sales predominantly take place between Airbus and Airbus Defence and Space and between Airbus Helicopters and Airbus. Consolidation effects are reported in the column "Eliminations".

    The Company uses EBIT as a key indicator of its economic performance. Business segment information for the year ended 31 March 2026 is as follows:

    (In € million)

    Airbus

    Airbus Helicopters

    Airbus Defence and Space

    Eliminations

    Airbus Consolidated

    Total revenue

    8,436

    1,604

    2,832

    0

    12,872

    Inter-segment revenue

    (117)

    (85)

    (19)

    0

    (221)

    Revenue

    8,319

    1,519

    2,813

    0

    12,651

    thereof:

    sales of goods at a point in time

    6,888

    474

    919

    0

    8,281

    sales of goods overtime

    0

    150

    954

    0

    1,104

    services, including sale of spare parts

    1,431

    895

    940

    0

    3,266

    Profit before financial result and income taxes (EBIT)

    1

    65

    134

    24

    224

    thereof research and development expenses

    (566)

    (76)

    (78)

    (10)

    (730)

    Interest result

    1

    Other financial result

    465

    Income taxes

    (139)

    Profit for the period

    551

    Business segment information for the year ended 31 March 2025 is as follows:

    (In € million)

    Airbus

    Airbus Helicopters

    Airbus Defence and Space

    Eliminations

    Airbus Consolidated

    Total revenue

    9,521

    1,600

    2,656

    0

    13,777

    Internal revenue

    (128)

    (88)

    (19)

    0

    (235)

    Revenue

    9,393

    1,512

    2,637

    0

    13,542

    thereof:

    sales of goods at a point in time

    7,965

    469

    803

    0

    9,237

    sales of goods overtime

    1

    157

    860

    0

    1,018

    services, including sale of spare parts

    1,427

    886

    974

    0

    3,287

    Profit before financial result and income taxes (EBIT)

    451

    78

    (31)

    (25)

    473

    thereof research and development expenses

    (545)

    (66)

    (57)

    (5)

    (673)

    Interest result

    20

    Other financial result

    601

    Income taxes

    (349)

    Profit for the period

    745

    • Airbus EBIT decreased by € -450 million to € 1 million (first three months 2025: € 451 million). It mainly reflects the lower deliveries of 114 aircraft (first three months 2025: 136 aircraft) and a less favourable foreign exchange environment.

    • Airbus Helicopters EBIT remained stable at € 65 million (first three months 2025: € 78 million).

    • Airbus Defence and Space EBIT increased by € +165 million to € 134 million (first three months 2025: € -31 million). It is mainly due to higher volume and better performance across Airbus Defence and Space businesses. The first three months 2025 included a charge of € -0.1 billion related to the associated costs of the adaptation plan announced in 2024.

  7. ‌Revenues and Gross Margin‌

    Revenue decreased by € -891 million to € 12,651 million (first three months 2025: € 13,542 million). The decrease is mainly driven by lower deliveries of 114 aircraft (first three months 2025: 136 aircraft) paired with a less favourable foreign exchange environment partly offset by higher volume across Airbus Defence and Space businesses.

    Revenue by geographical areas based on the location of the customer is as follows:

    (In € million)

    1 January -

    31 March 2026

    1 January -

    31 March 2025

    Europe

    5,613

    5,567

    Asia-Pacific

    2,753

    4,028

    North America

    1,946

    2,662

    Middle East

    1,426

    615

    Latin America

    416

    370

    Other countries

    497

    300

    Total

    12,651

    13,542

    The gross margin decreased by € -322 million to € 1,556 million compared to € 1,878 in the first three months 2025. It is mainly due to lower aircraft deliveries paired with a less favourable foreign exchange environment partly offset by higher volume and better performance across Airbus Defence and Space businesses.

    The gross margin rate decreased from 13.9% to 12.3%.

  8. ‌Research and Development Expenses‌

    Research and development expenses increased by € 57 million to € 730 million compared to € 673 million in the first three months 2025.

    Research and development expenses mainly reflect the development of latest generation commercial aircraft programmes and activities to prepare technologies of the future.

  9. ‌Other Income and Other Expenses‌

    Other income increased by € +22 million to € 55 million compared to € 33 million in the first three months 2025.

    Other expenses decreased by € 83 million to € -38 million compared to € -121 million in the first three months 2025 mainly due to the restructuring provision related to the Airbus Defence and Space adaptation plan announced in 2024 and recorded in the first three months 2025.

  10. ‌Share of Profit from Investments Accounted for under the Equity Method and Other Income from Investments‌

    Share of profit from investments under the equity method and other income from investments remained stable at € 20 million compared to € 21 million in the first three months 2025.

  11. ‌Total Financial Result‌

    Total financial result decreased by € -155 million to € 466 million compared to € 621 million in the first three months 2025. The financial result mainly reflects the revaluation of certain equity investments (see "- Note 15: Other Investments and Other Long-Term Financial Assets").

  12. ‌Income Taxes‌

    The income tax expense amounts to € -139 million (first three months 2025: € -349 million) and corresponds to an effective income tax rate of 20.2%. This is related to the non-taxable impact from the revaluation of certain financial investments partly offset by the effect of the French surtax.

  13. ‌Earnings per share‌

    (In € million)

    1 January -

    31 March 2026

    1 January -

    31 March 2025

    Profit for the period attributable to equity owners of the parent (Net income)

    € 586 million

    € 793 million

    Weighted average number of shares outstanding

    787,227,745

    787,433,498

    Basic earnings per share

    € 0.74

    € 1.01

    Diluted earnings per share - The Company's dilutive potential ordinary shares are equity-settled Performance Shares relating to

    Long-Term Incentive Plans ("LTIP").

    In the first three months 2026, a total of 1,406,067 equity-settled Performance Shares was considered in the calculation of diluted earnings per share.

    (In € million)

    1 January -

    31 March 2026

    1 January -

    31 March 2025

    Profit for the period attributable to equity owners of the parent (Net income)

    € 586 million

    € 793 million

    Weighted average number of shares outstanding (diluted)

    788,633,812

    788,579,719

    Diluted earnings per share

    € 0.74

    € 1.01

  14. ‌Investments Accounted for under the Equity Method‌

    Investments accounted for under the equity method remained stable at € 2,375 million (prior year-end: € 2,360 million). They mainly include the equity investments in ArianeGroup, MBDA and ATR GIE.

  15. ‌Other Investments and Other Long-Term Financial Assets‌

    (In € million)

    31 March 2026

    31 December 2025

    Other investments

    3,843

    3,499

    Other long-term financial assets

    1,770

    1,971

    Total non-current other investments and other long-term financial assets

    5,613

    5,470

    Current portion of other long-term financial assets

    905

    734

    Total

    6,518

    6,204

    Other investments mainly comprise the Company's participations and include the remaining investment in Dassault Aviation (10.65%, prior year-end: 10.56%) amounting to € 2,641 million as of 31 March 2026 (prior year-end: € 2,266 million).

    Other long-term financial assets and the current portion of other long-term financial assets include other loans in the amount of

    € 2,551 million as of 31 March 2026 (prior year-end: € 2,613 million), and the sales financing activities in the form of finance lease receivables and loans from aircraft financing.

  16. ‌Inventories‌

    Inventories of € 46,922 million (prior year-end: € 41,676 million) increased by € +5,246 million. This is mostly driven by work in progress in order to support the ramp-up and higher level of finished goods.

  17. ‌Provisions‌

    (In € million)

    31 March 2026

    31 December 2025

    Provisions for pensions

    1,115

    1,255

    Other provisions

    6,807

    7,090

    Total provisions

    7,922

    8,345

    Non-current provisions

    3,759

    3,976

    Current provisions

    4,163

    4,369

    As of 31 March 2026, provisions for pensions amount to € 1.1 billion (prior year-end: € 1.3 billion). It mainly reflects the actuarial gains on pension obligations from financial assumptions driven by the increase in the discount rates and the contributions to plan assets. It is partly offset by low performance on plan assets.

    As of 31 March 2026, a non-current asset of € 1.0 billion (prior year-end: € 0.8 billion) has been accounted for to reflect the surplus in two pension funds in the UK, the Airbus Section of the participation in BAE Systems Pension Scheme and the Company UK Pension Scheme, the Airbus Atlantique Pension Plan in Canada, as well as the German deferred compensation. (see "- Note 19: Other Assets and Other Liabilities").

    Other provisions decreased by € -284 million to € 6,806 million (prior year-end: € 7,090 million). It is mainly due to the utilisation of provisions for onerous contracts.

  18. ‌Other Financial Assets and Other Financial Liabilities‌

    Other Financial Assets

    (In € million)

    31 March 2026

    31 December 2025

    Positive fair values of derivative financial instruments (1)

    633

    1,050

    Others

    21

    20

    Total non-current other financial assets

    654

    1,070

    Receivables from related companies

    1,349

    1,426

    Positive fair values of derivative financial instruments (1)

    571

    771

    Others

    429

    360

    Total current other financial assets

    2,349

    2,557

    Total

    3,003

    3,627

    1. See "- Note 22: Financial Instruments".

      Other Financial Liabilities

      (In € million)

      31 March 2026

      31 December 2025

      Liabilities for derivative financial instruments (1)

      1,407

      1,107

      European Governments' refundable advances (2)

      3,611

      3,620

      Others

      79

      82

      Total non-current other financial liabilities

      5,097

      4,809

      Liabilities for derivative financial instruments (1)

      641

      414

      European Governments' refundable advances (2)

      206

      202

      Liabilities to related companies

      68

      80

      Others

      349

      304

      Total current other financial liabilities

      1,264

      1,000

      Total

      6,361

      5,809

      1. See "- Note 22: Financial Instruments".

      2. Refundable advances from European Governments are provided to the Company to finance research and development activities for certain projects on a risk-sharing basis, i.e. they are repaid to the European Governments subject to the success of the project.

      The total net fair value of derivative financial instruments decreased by € -1,144 million to € -844 million (prior year-end: € 300 million) as a result of the strengthening of the US dollar spot rate in the first three months 2026.

      In the first three months 2026, the European Governments' refundable advances remained stable at € 3,817 million (prior year-end:

      € 3,822 million).

      The allocation of European Governments' refundable advances between non-current and current presented in the Condensed Interim IFRS Consolidated Financial Information ended 31 March 2026 is based on the applicable contractual repayment dates.

  19. ‌Other Assets and Other Liabilities‌

    Other Assets

    (In € million)

    31 March 2026

    31 December 2025

    Cost to fulfil a contract

    735

    715

    Prepaid expenses

    47

    46

    Others

    2,291

    2,001

    Total non-current other assets

    3,073

    2,762

    Value added tax claims

    2,037

    1,924

    Cost to fulfil a contract

    740

    683

    Prepaid expenses

    793

    766

    Others

    380

    387

    Total current other assets

    3,950

    3,760

    Total

    7,023

    6,522

    As of 31 March 2026, others included into other assets comprise € 1,405 million of payments to be made to Airbus by suppliers after aircraft delivery (prior year-end: € 1,319 million) which are expected to be received over a rolling period of 15 years. They are recorded as a reduction of cost of goods sold at the time of aircraft delivery. These future payments are discounted to reflect specific contractual terms and repayment profile.

    As of 31 March 2026, a non-current asset of € 982 million (prior year-end: € 781 million) is accounted for in others to reflect the surplus in two pension funds in the UK (see "- Note 17: Provisions").

    Other Liabilities

    (In € million)

    31 March 2026

    31 December 2025

    Others (1)

    450

    477

    Total non-current other liabilities

    450

    477

    Tax liabilities (excluding income tax)

    1,076

    871

    Others (1)

    4,215

    3,352

    Total current other liabilities

    5,291

    4,223

    Total

    5,741

    4,700

    1. "Others" mainly comprises tax (excluding income tax) and personnel liabilities (e.g. Salaries, Social insurance contribution, Liabilities from personnel restructuring).

  20. ‌Total Equity‌

    The Company's shares are exclusively ordinary shares with a par value of € 1.00. The following table shows the development of the number of shares issued and fully paid:

    (In number of shares)

    31 March 2026

    31 December 2025

    Issued as at 1 January

    792,283,683

    792,283,683

    Issued for ESOP

    0

    0

    Issued as at end of the period

    792,283,683

    792,283,683

    Treasury shares

    (5,055,558)

    (5,055,938)

    Outstanding as at end of the period

    787,228,125

    787,227,745

    Holders of ordinary shares are entitled to dividends and to one vote per share at general meetings of the Company.

    Equity attributable to owners of the parent (including purchased treasury shares) amounts to € 26,091 million (prior year-end:

    € 26,104 million) representing a decrease of € -13 million. This is mainly due to the mark to market revaluation of the hedge portfolio of

    € -819 million partly compensated by the net income for the period of € +586 million and the 2026 employee share ownership plan ("ESOP") campaign with share-based payment of € +234 million.

    The non-controlling interests ("NCI") from non-wholly owned subsidiaries increased to € 88 million as of 31 March 2026 (prior year-end: € 80 million). These NCI do not have a material interest in the Company's activities and cash flows.

  21. ‌Net Cash‌

    The net cash is comprised of the following elements:

    (In € million)

    31 March 2026

    31 December 2025

    Cash and cash equivalents

    11,872

    14,128

    Current securities

    2,999

    3,093

    Non-current securities

    10,366

    9,997

    Gross cash position

    25,237

    27,218

    Short-term financing liabilities

    (5,515)

    (5,186)

    Long-term financing liabilities

    (9,055)

    (9,063)

    Interest rate contracts

    (818)

    (798)

    Total

    9,849

    12,171

    The net cash position on 31 March 2026 amounted to € 9,849 million (prior year-end: € 12,171 million), with a gross cash position of € 25,237 million (prior year-end: € 27,218 million).

    Cash and Cash Equivalents

    Cash and cash equivalents are composed of the following elements:

    (In € million)

    31 March 2026

    31 December 2025

    Bank account and petty cash

    5,941

    7,387

    Short-term securities (at fair value through profit or loss)

    4,844

    5,004

    Short-term securities (at fair value through OCI)

    1,087

    1,737

    Total cash and cash equivalents

    11,872

    14,128

    Only securities with a maturity of three months or less from the date of the acquisition, that are readily convertible to known amounts of cash and which are subject to an insignificant risk of changes in value, are recognised in cash equivalents.

    Cash and cash equivalents have decreased by € +2.2 billion from € 14.1 billion as of 31 December 2025 to € 11.9 billion as of 31 March 2026.

    The main variations are as follows:

    Cash provided by operating activities amounts to € -1.9 billion in the first three months 2026, driven by inventory build-up partly offset by a profit translated into cash and a positive impact from contract assets and liabilities.

    Cash used for investing activities amounts to € 0.8 billion, mainly reflecting capital expenditure and investments in securities. Cash used for financing activities amounts to € 0.2 billion.

    Financing Liabilities

    (In € million)

    31 March 2026

    31 December 2025

    Bonds and commercial papers

    6,297

    6,286

    Liabilities to financial institutions

    320

    329

    Loans

    393

    395

    Lease liabilities

    2,045

    2,053

    Total long term financing liabilities

    9,055

    9,063

    Bonds and commercial papers

    1,491

    1,479

    Liabilities to financial institutions

    2

    25

    Loans

    75

    129

    Lease liabilities

    324

    327

    Others (1)

    3,623

    3,226

    Total short term financing liabilities

    5,515

    5,186

    Total

    14,570

    14,249

    (1) Included in "others" are financing liabilities to joint ventures.

    Long-term financing liabilities, mainly comprising of bonds and lease liabilities,remained stable at € 9,055 million (prior year-end: € 9,063 million).

    Short-term financing liabilities increased by € +329 million to € 5,515 million (prior year-end: € 5,186 million).

    On 31 January 2023, the Company signed a lease agreement with Mobile Airport Authority ("MAA") for a new Final Assembly Line designed by Airbus and to be constructed in Mobile, Alabama on MAA owned land. The expected cost of construction is funded through the issuance of bonds by MAA for a nominal amount of US$ 1.0 billion, the proceeds of which are used solely for that purpose. The bonds are fully guaranteed by the Company which is supervising the construction and is liable for any cost overruns. As of 31 March 2026, the project has entered into service for a corresponding amount of US$ 939 million (no entry into service has been recorded in the first three months 2026). In accordance with IFRS 16 and the Company's accounting policies for the classification of interests' cash flows, the lease liability payments to be made over the lease term is recognised in financing cash flows for the principal portion and in operating cash flows for the interest portion.

  22. ‌Financial Instruments‌

    The following table presents the composition of derivative financial instruments:

    (In € million)

    31 March 2026

    31 December 2025

    Non-current positive fair values

    633

    1,050

    Current positive fair values

    571

    771

    Total positive fair values of derivative financial instruments

    1,204

    1,821

    Non-current negative fair values

    (1,407)

    (1,107)

    Current negative fair values

    (641)

    (414)

    Total negative fair values of derivative financial instruments

    (2,048)

    (1,521)

    Total net fair values of derivative financial instruments

    (844)

    300

    The total net fair value of derivative financial instruments decreased by € -1,144 million to € -844 million (prior year-end: € 300 million) as a result of the strengthening of the US dollar spot rate in the first three months 2026.

    As of 31 March 2026, the total hedge portfolio with maturities up to 2030 amounts to US$ 56.2 billion (prior year-end: US$ 54.2 billion) and covers a significant portion of the foreign exchange exposure expected over the hedging horizon. The average US$/€ hedge rate of the US$/€ hedge portfolio until 2030 amounts to 1.23 US$/€ (prior year-end: 1.22 US$/€).

    Carrying Amounts and Fair Values of Financial Instruments

    Fair values of financial instruments have been determined with reference to available market information at the end of the reporting period and the valuation methodologies as described in detail in Note 37.2 to the 2025 IFRS Consolidated Financial Statements. For the first three months 2026, the Company has applied the same methodologies for the fair value measurement of financial instruments.

    Carrying amount is a reasonable approximation of fair value for all classes of financial instruments listed in the first table of Note 37.2 to the 2025 IFRS Consolidated Financial Statements, with the exception of:

    31 March 2026

    31 December 2025

    (In € million)

    Book Value

    Fair Value

    Book Value

    Fair Value

    Financing liabilities

    Issued bonds and commercial papers

    (7,788)

    (8,046)

    (7,765)

    (8,113)

    Liabilities to banks and other financing liabilities

    (4,413)

    (4,413)

    (4,104)

    (4,104)

    Fair Value Hierarchy

    Depending on the extent the inputs used to measure fair values rely on observable market data, fair value measurements may be hierarchised according to the following levels of input:

    • Level 1: quoted prices (unadjusted) in active markets for identical assets and liabilities;

    • Level 2: inputs other than quoted prices that are observable for the asset or liability - fair values measured based on Level 2 input typically rely on observable market data such as interest rates, foreign exchange rates, credit spreads or volatilities;

    • Level 3: inputs for the asset or liability that are not based on observable market data - fair values measured based on Level 3 input rely to a significant extent on estimates derived from the Company's own data and may require the use of assumptions that are inherently judgemental and involve various limitations.

    The fair values disclosed for financial instruments accounted for at amortised cost reflect Level 2 input. Otherwise, the Company determines mostly fair values based on Level 1 and Level 2 inputs and to a lesser extent on Level 3 input.

    The following table presents the carrying amounts of the financial instruments held at fair value across the three levels of the fair value hierarchy:

    31 March 2026

    31 December 2025

    (In € million)

    Level 1

    Level 2

    Level 3

    Total

    Level 1

    Level 2

    Level 3

    Total

    Financial assets measured at fair value

    Equity instruments

    2,868

    0

    975

    3,843

    2,645

    0

    854

    3,499

    Derivative instruments

    0

    1,204

    0

    1,204

    0

    1,821

    0

    1,821

    Securities

    13,365

    0

    0

    13,365

    13,090

    0

    0

    13,090

    Customer financing

    0

    0

    125

    125

    0

    0

    92

    92

    Cash equivalents

    4,844

    1,087

    0

    5,931

    5,004

    1,737

    0

    6,741

    Total

    21,077

    2,291

    1,100

    24,468

    20,739

    3,558

    946

    25,243

    Financial liabilities measured at fair value

    Derivative instruments

    0

    (2,048)

    0

    (2,048)

    0

    (1,521)

    0

    (1,521)

    Other liabilities

    0

    0

    0

    0

    0

    0

    0

    0

    Total

    0

    (2,048)

    0

    (2,048)

    0

    (1,521)

    0

    (1,521)

    As of 31 March 2026, the fair value of the written put options on non-controlling interests ("NCI puts") relating to ACLP amounts to € 0 million (prior year-end: € 0 million).

    The fair value of these NCI puts is derived from a discounted cash flow analysis using the latest operating plan and a projection over the lifetime of the A220 programme. In addition, a post-tax WACC of 8.77% is used to discount the forecasted cash flows, taking into account the specificities of the programme (prior year-end: 8.77%).

  23. ‌Litigation and Claims‌

    The Company is involved from time to time in various governmental, legal and arbitration proceedings in the ordinary course of its business, the most significant of which are described below. Other than as described below, there are no material governmental, legal or arbitration proceedings (including any such proceedings which are pending or threatened) which may have or have had in the recent past significant effects on Airbus SE's or the Company's Financial Position or profitability.

    If the Company concludes that the disclosures relative to contingent liabilities can be expected to prejudice seriously its position in a dispute with other parties, the Company limits its disclosures to the nature of the dispute.

    Securities Litigation

    In August 2021 the Company received notification of two separate claims, and in March 2022 of a third claim, each filed in the Netherlands purportedly on behalf of Airbus investors. These claims (the "Dutch claims") were made in relation to the previously reported criminal investigations that led to the Company's agreements with the French Parquet National Financier ("PNF"), the UK Serious Fraud Office ("SFO"), the US Department of Justice ("DoJ") and the US Department of State ("DoS"), which were approved on 31 January 2020. The Dutch claims assert that the Company violated its reporting obligations, allegedly leading to an impact on the Company's share price, by failing to adequately inform investors and providing false or misleading information about the criminal investigations, the Company's use of intermediaries and alleged corrupt practices, and its related financial exposure, internal investigations and subsequent measures taken by the Company.

    The first Dutch claim was filed with the Amsterdam District Court in August 2021 by a special purpose vehicle incorporated under the laws of Guernsey, an assignee purportedly representing numerous private shareholders and institutional investors, seeking a declaratory judgment with damages to be assessed in follow on proceedings.

    The second Dutch claim was filed in December 2021 following a demand letter sent by a foundation incorporated under the laws of the Netherlands, a purported representative of unnamed institutional and retail investors worldwide, starting a class action against the Company before the Dutch courts. This second Dutch claim targets the Company and its former auditors, Ernst & Young. The third Dutch claim was a class action filed in April 2022 against the Company by a foundation incorporated under the laws of the Netherlands. In accordance with Dutch procedural law, the two Dutch class action claims were treated jointly as one case.

    The Dutch claims followed the filing in 2020 of a putative class action lawsuit in US federal court in the state of New Jersey, against Airbus SE and members of its current and former management. The US complaint asserted violations of US securities laws, alleging false and misleading statements or omissions concerning, among other things, the Company's agreements approved on 31 January

    2020 with the French PNF, the UK SFO, the US DoJ and the US DoS as well as the Company's historic practices regarding the use of third party business partners and anti-corruption compliance. The matter was fully and finally settled on 30 September 2022 in exchange for a payment in the amount of US$ 5 million without any acknowledgement of liability.

    In August 2023 the first Dutch claim was dismissed on the merits, with the plaintiff appealing this dismissal in November 2023. The second and third Dutch claims were dismissed on procedural grounds in September 2023, which plaintiffs appealed in December of that year. The first and third Dutch claims were fully and finally settled on 30 November 2024 for a non-material amount, without any acknowledgement of liability. On 23 December 2025 the Hague Court of Appeal affirmed the lower court's dismissal of the second Dutch claim, and the plaintiff appealed to the Supreme Court of the Netherlands in March 2026.

    Even should the Supreme Court allow the final claim to be reinstated, the Company believes it has strong grounds to defend the claim on the merits. The consequences of such litigation and the outcome of the proceedings cannot be fully assessed at this stage, but any judgment or decision unfavourable to the Company could have a material adverse impact on the Financial Statements, business and operations of the Company.

    Air France Flight 447 Trial

    On 1 June 2009, an A330 operated by Air France as flight AF447 from Rio de Janeiro to Paris disappeared over the Atlantic Ocean with 228 persons onboard. The wreckage was located in April 2011 after several search campaigns organised by the Bureau d'Enquêtes et d'Analyses (BEA), which published its final investigation report in July 2012. In the wake of the accident, the prosecutor in Paris opened an investigation for involuntary manslaughter and Airbus SAS was charged in March 2011. In September 2019, the investigating magistrates closed the investigation and dismissed all criminal charges after a thorough analysis of the technical and criminal legal elements of the case. However, the Paris Court of Appeal overturned the magistrates' decision and ordered a trial for involuntary manslaughter. The Company's appeal to the French Supreme Court was dismissed. Following a trial in the fourth quarter of 2022, the Paris Criminal Court announced in April 2023 that all criminal charges against the Company were dismissed, but sustained certain civil liability claims. The Paris General Prosecutor appealed the dismissal of criminal charges against Airbus and Air France, and a full retrial of the matter was held before the Paris Court of Appeal in the autumn of 2025, with a verdict scheduled for May 2026.

    HMRC Export Control Investigation

    Airbus is fully cooperating with an investigation by the Revenue and Customs Authority of the United Kingdom into possible violations of the United Kingdom's export control rules. It is not expected that the resolution of this matter will have a material financial impact.

  24. ‌Number of Employees‌

    Airbus

    Airbus Helicopters

    Airbus Defence

    and Space

    Consolidated

    Airbus

    31 March 2026

    106,128

    24,384

    36,364

    166,876

    31 December 2025

    105,128

    23,922

    36,244

    165,294

    As of 31 March 2026, the total number of employees amounts to 166,876 (prior year-end: 165,294).

  25. ‌Events after the Reporting Date‌

On 21 April 2026, Airbus has entered into an agreement for the acquisition of the French cybersecurity company Quarkslab, primarily based in Paris and Rennes, France. Closing of the transaction is subject to consultation with social partners as well as customary regulatory approvals, and is expected in the course of 2026.